510(k) Report

510(k) · Cleared

Cleared

VivoSight Dx Topical OCT System

K153283510(k) TraditionalCleared Aug 11, 2016273-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Michelson Diagnostics, Ltd. · NQQ System, Imaging, Optical Coherence Tomography (Oct)

Cleared on Aug 11, 2016 after a 273-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 2 later devices descend from it.

Decided
Aug 11, 2016
Review
273 days
Class
Class II
Product code
NQQ
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared2025: 1 descendant cleared201620182020202220242026
  1. This deviceK153283 VivoSight Dx Topical OCT SystemMichelson Diagnostics, Ltd. · 2016
  2. Descendant · cites it directly · 1 of its ownK240610 deepLiveDamae Medical · 2024
  3. Descendant · 2 generations on · 0 of its ownK252851 deepLive (OSP12 + DMS)Damae Medical · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K240610deepLiveDamae Medical · 2024 · cites it directly1descendant
  • K252851deepLive (OSP12 + DMS)Damae Medical · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K153283VivoSight Dx Topical OCT SystemMichelson Diagnostics, Ltd.2016—
+1K240610deepLiveDamae Medical2024—
+2K252851deepLive (OSP12 + DMS)Damae Medical2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
202510
FIG. 1 — Lineage of K153283, 2016–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NQQ device

  1. #1 K251730 LIA Console (542-7)score 16.2 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K240610deepLiveDamae Medical20241

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K240610 (Damae Medical, 2024) has gone furthest, with 1 descendant of its own.

How does its category compare?

All NQQ devices

NQQ System, Imaging, Optical Coherence Tomography (Oct): FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · NQQ

8in 2025

2010: 32011: 22012: 12013: 22014: 22015: 52016: 52017: 12018: 22019: 32020: 22021: 22023: 32024: 22025: 82026 (partial year): 1
2007high 8 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQQ

146in 2025

2010: 82 days median2015: 91 days median2016: 91 days median2019: 84 days median2023: 86 days median2025: 146 days median
2007high 146 (2025) · low 82 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NQQ

1in 2011

2010: 12011: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQQ

2in 2025

2011: 22012: 52013: 32014: 12015: 32016: 22017: 32018: 42019: 62020: 42021: 32022: 42023: 62024: 62025: 2
2007high 6 (2019) · low 0 (2007)2025

MAUDE reports naming product code NQQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
201038210
20112—12
20121—05
20132—03
20142—01
201559103
201659102
20171—03
20182—04
201938406
20202—04
20212—03
20220—04
202338606
20242—06
2025814602
20261—0—

What is it indicated for?

VivoSight Dx is a Multi-Beam Optical Coherence Tomography (OCT) system indicated for use in the two-dimensional, cross-sectional, real-time imaging of external tissues of the human body.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K153283: VivoSight Dx Topical OCT System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K153283

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026